
Compartir
Título
Autism care pathway in Europe
Autor(es)
Palabras clave
Autism
Diagnosis
Early intervention
Early screening
Policy recommendations
Clasificación UNESCO
61 Psicología
3212 Salud Publica
6105 Evaluación y Diagnostico en Psicología
Fecha de publicación
2023-09-11
Editor
Cambridge University Press
Citación
Mendez, Maria A., et al. «Autism Care Pathway in Europe». European Psychiatry, vol. 66, n.o 1, 2023, p. e81. DOI.org (Crossref), https://doi.org/10.1192/j.eurpsy.2023.2435.
Resumen
[EN] Background. Autism is a lifelong complex neurodevelopmental condition that affects brain development and behaviour with significant consequences for everyday life. Despite its personal, familial, and societal impact, Europe-wide harmonised guidelines are still lacking for early detection, diagnosis, and intervention, leading to an overall unsatisfactory autistic person and carer journey.
Methods. The care pathway for autistic children and adolescents was analysed in Italy, Spain and the UK from the perspective of carers (using a survey aimed at caregivers of autistic children 0–18 years old), the autistic community, and professionals in order to identify major barriers (treatment gaps) preventing carers from receiving information, support, and timely screening/ diagnosis and intervention.
Results. Across all three countries, analysis of the current care pathway showed: long waits from the time carers raised their first concerns about a child’s development and/or behaviour until screening and confirmed diagnosis; delayed or no access to intervention once a diagnosis was confirmed; limited information about autism and how to access early detection services; and deficient support for families throughout the journey.
Conclusions. These findings call for policy harmonisation in Europe to shorten long wait times for diagnosis and intervention and therefore, improve autistic people and their families’ journey experience and quality of life.
URI
ISSN
0924-9338
DOI
10.1192/J.EURPSY.2023.2435
Versión del editor
Aparece en las colecciones
Patrocinador
EU/EFPIA/ SFARI/Autistica/AUTISM SPEAKS Innovative Medicines Initiative 2 Joint Undertaking (AIMS-2-TRIALS grant n° 777394)













